Smith & Nephew PLC
LSE:SN

Watchlist Manager
Smith & Nephew PLC Logo
Smith & Nephew PLC
LSE:SN
Watchlist
Price: 1 230 GBX -1.05% Market Closed
Market Cap: £10.5B

Operating Margin

20.2%
Current
Improving
by 3.5%
vs 3-y average of 16.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
20.2%
=
Operating Income
$891m
/
Revenue
$5.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
20.2%
=
Operating Income
GBX891m
/
Revenue
$5.9B

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Smith & Nephew PLC
LSE:SN
10.8B GBP
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Higher than 98% of companies in United Kingdom
Percentile
98th
Based on 3 579 companies
98th percentile
20.2%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Smith & Nephew PLC
Glance View

Smith & Nephew PLC, a name synonymous with innovation in the medical technology sphere, began its journey in the late 19th century in the quaint city of Kingston upon Hull, England. This humble pharmaceutical shop evolved over time into a global leader in medical devices, driven by a commitment to improve people's quality of life through pioneering healthcare solutions. Today, the company stands as a key player in three core sectors: orthopedics, advanced wound management, and sports medicine. By focusing on these specialized areas, Smith & Nephew has set itself apart, effectively addressing the complex challenges faced by aging populations and a rising demand for minimally invasive treatments. Revenue streams pour in from their innovative products, which cater to both healthcare professionals and patients worldwide. In orthopedics, they make significant headway with implants and instruments used in hip and knee replacements, essential solutions in addressing joint deterioration and injury. Their advanced wound management division tackles issues from chronic wounds to burns, supplying dressings and delivery systems designed for optimal healing. Meanwhile, the sports medicine segment contributes by offering arthroscopy and enabling technologies, crucial for athletic injury prevention and recovery. By maintaining a strong pipeline of research and development initiatives, Smith & Nephew continues to enhance its offerings, pushing the envelope in medical technology and consequently fortifying its financial foundation.

SN Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
20.2%
=
Operating Income
$891m
/
Revenue
$5.9B
What is Smith & Nephew PLC's current Operating Margin?

The current Operating Margin for Smith & Nephew PLC is 20.2%, which is above its 3-year median of 16.7%.

How has Operating Margin changed over time?

Over the last 3 years, Smith & Nephew PLC’s Operating Margin has increased from 16.9% to 20.2%. During this period, it reached a low of 14.2% on Jul 1, 2023 and a high of 20.6% on Jun 28, 2025.

Back to Top